首页> 外文会议>World biomaterials congress >Electrospun fibrous platforms as 3D in vitro model for screening chemotherapeutic drug effect in tissue regeneration and cancer therapy
【24h】

Electrospun fibrous platforms as 3D in vitro model for screening chemotherapeutic drug effect in tissue regeneration and cancer therapy

机译:电纺纤维平台作为3D体外模型,用于筛选组织再生和癌症治疗中化疗药物的作用

获取原文

摘要

Introduction: All tissues - i.e., healthy and cancerous ones - are composed of cells regulating body processes, maintenance and wound healing, and the extracellular matrix (ECM) - a chemically and structurally complex matter able to dynamically influence phenotypicot phenotypic cell involved in regeneration and degeneration processes. Recently, much more attention has been referred to the definition of 3D in vitro tissue models able to reproduce ECM functionalities, by controlling molecular transport for an optimal administration of biochemical signals (i.e., growth factors, drugs) to guide cells fate in different ways. In this context, engineered scaffolds may provide a support matrix with ECM-like physical/structural properties suitable to in vitro reproduce all the main functionalities that healthy tissue or tumor microenvironment exert in vivo. In particular, electrospinning is emerging as an interesting microano-fabrication technique to develop 3D platforms to predict the effect of chemotherapeutic drugs on in vitro cell activities. Here, we investigate how Poly-ε-caprolactone (PCL) electrospun scaffolds may influence the behavior of hMSC or tumor cells (i.e., hepatocarcinoma) in response to different chemotherapeutic molecules administration in order to validate their use as in vitro model for tissue engineering and cancer therapy. Materials and Methods: PCL fibers were produced by electrospinning technique, dissolving the polymer in chloroform (0.33 g/ml). hMSC and Hep G2 cells were seeded onto PCL electrospun fibers. Cell survival was analyzed by MTT assay. In particular, hMSC differentiation was analyzed by YIP-1B expression in presence or in absence of 5-AZA (1 and 5uM). Meanwhile, Hep G2 proliferation was evaluated by Brdu ELISA in the presence of doxorubicin (0.4 and 0.8 μM). In both cases, qualitative cell attachment was observed by FESEM analysis. Results and Discussion: We demonstrated that PCL fibers did not exert a cytotoxic effect on hMSCs, whereas they may reduce Hep G2 cell viability compared to plate control. SEM clearly showed hMSC and Hep G2 adhesion onto electrospun PCL fibers. Brdu assay suggested that PCL without doxorubicin significantly inhibited Hep G2 proliferation compared to plate control, but did not improve the effect of doxorubicin on Hep G2 proliferation. Contrariwise, in the case of hMSCs treated with 5-AZA, PCL fibers significantly increased YIP-1B expression - as index of myogenic differentiation, compared to plate control. Conclusion: We demonstrate that 3D fibrous network with the structural organization of ECM collagen fibers may influence interactions among cells mediated by chemotherapeutic drugs. This may open new interesting routes in drug administration to minimize side effects while preserving therapeutic benefits, thus concurring to the definition of more efficacious preclinical models for tissue regeneration/degeneration.
机译:简介:所有组织(即健康和癌性组织)均由调节身体进程,维持和伤口愈合的细胞以及细胞外基质(ECM)组成,细胞外基质是一种化学和结构复杂的物质,能够动态影响所涉及的表型/非表型细胞再生和变性过程。近来,已经更多地关注能够通过控制分子运输以最佳地施用生化信号(即生长因子,药物)以不同方式引导细胞命运的分子复制而能够再现ECM功能的3D体外组织模型的定义。在这种情况下,工程支架可以提供具有类似于ECM的物理/结构特性的支持基质,该支持基质适合于体外再现健康组织或肿瘤微环境在体内发挥的所有主要功能。特别地,静电纺丝作为一种有趣的微/纳米加工技术正在兴起,以开发3D平台来预测化学治疗药物对体外细胞活性的影响。在这里,我们研究了聚ε-己内酯(PCL)电纺丝支架如何影响hMSC或肿瘤细胞(即肝癌)响应不同的化学治疗分子的行为,以验证其在体外用于组织工程和肿瘤模型的作用。癌症治疗。材料和方法:PCL纤维是通过静电纺丝技术生产的,将聚合物溶于氯仿(0.33 g / ml)中。将hMSC和Hep G2细胞接种到PCL电纺丝上。通过MTT测定法分析细胞存活。特别地,通过存在或不存在5-AZA(1和5uM)的YIP-1B表达来分析hMSC的分化。同时,在阿霉素(0.4和0.8μM)存在下,通过Brdu ELISA评估了Hep G2的增殖。在两种情况下,通过FESEM分析观察到定性细胞附着。结果与讨论:我们证明PCL纤维对hMSC没有细胞毒性作用,而与平板对照相比,它们可能会降低Hep G2细胞的活力。 SEM清楚地显示出hMSC和Hep G2粘附在电纺PCL纤维上。 Brdu分析表明,无阿霉素的PCL与平板对照相比可显着抑制Hep G2的增殖,但并未改善阿霉素对Hep G2增殖的影响。相反,在用5-AZA处理的hMSC中,与板对照相比,PCL纤维显着增加了YIP-1B的表达-作为成肌分化的指标。结论:我们证明具有ECM胶原纤维结构的3D纤维网络可能会影响化疗药物介导的细胞之间的相互作用。这可能会在药物给药方面开辟新的有趣途径,以最大程度地减少副作用,同时保留治疗益处,从而同意为组织再生/变性定义更有效的临床前模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号